Experts provide an update on HBV, HCV, and HEV infections in immunocompromised patients, focusing on viral reactivation after immunosuppressive treatment. Topics include: various types reactivation of viral hepatitis; at-risk patient populations; diagnostic criteria for reactivation of HBV, HCV, and HEV infection; preventive measures; effects of specific immunosuppressive therapies; and timing of antiviral treatment.
Describe and contrast the various types of reactivation of viral hepatitis and the different patient populations that are at risk.
Review and discuss the diagnostic criteria for reactivation of HBV, HCV, and HEV.
Discuss preventive measures, the effects of specific immunosuppressive therapies, benefits, and the timing of antiviral treatment for patients experiencing reactivation of viral hepatitis.